Our Story
- About the NPC Therapy Accelerator
- Oversight Committee
What is NPC Disease?
Research Collaboration
Therapies
Get Involved
- Foundations, Organizations & Conferences
- Funding Opportunities
Contact

Our Story
- About the NPC Therapy Accelerator
- Oversight Committee
What is NPC Disease?
Research Collaboration
Therapies
Get Involved
- Foundations, Organizations & Conferences
- Funding Opportunities
Contact

Home The Blog press release from Orphazyme concerning Arimoclomol

press release from Orphazyme concerning Arimoclomol

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.

Search

Recent Posts

NPC Listening Session with the FDA on August 3rd – Final Report
Pfreigers digest September 2021
Letter from the NPC community following the FDA Listening Session on August 3, 2021
press release from Orphazyme concerning Arimoclomol
Notes from NPC Accelerator Meeting – 5-26-21

Recent Comments

Archives

September 2021
August 2021
June 2021
May 2021
February 2021
January 2021
September 2020
May 2020

Categories

News
Trending Research
Uncategorized

Meta

Log in
Entries feed
Comments feed
WordPress.org

Quick Access

Our Story
- About the NPC Therapy Accelerator
- Oversight Committee
What is NPC Disease?
Research Collaboration
Therapies
Get Involved
- Foundations, Organizations & Conferences
- Funding Opportunities
Contact

© 2021 Ara Parseghian Medical Research Fund
Website by: Brandon Tabor

Our Story
- About the NPC Therapy Accelerator
- Oversight Committee
What is NPC Disease?
Research Collaboration
Therapies
Get Involved
- Foundations, Organizations & Conferences
- Funding Opportunities
Contact